Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma

Documenti analoghi

• Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils
  di: Kathleen M. Buchheit, et al.
  Pubblicazione: (2024)
• Type 2‐high airway inflammation in childhood asthma distinguishes a more severe phenotype
  di: Frederikke R. Skov, et al.
  Pubblicazione: (2025)
• Species‐level, metagenomic and proteomic analysis of microbe‐immune interactions in severe asthma
  di: Maisha F. Jabeen, et al.
  Pubblicazione: (2024)
• Benralizumab in children with severe eosinophilic asthma: Pharmacokinetics and long‐term safety ( TATE study)
  di: H. James Wedner, et al.
  Pubblicazione: (2024)
• Tissue‐specific contribution of mucosal‐associated invariant T cells to allergic airway inflammation
  di: Alissa Cait, et al.
  Pubblicazione: (2024)